MX2011004284A - Metodo para tratar la hipertension arterial pulmonar. - Google Patents
Metodo para tratar la hipertension arterial pulmonar.Info
- Publication number
- MX2011004284A MX2011004284A MX2011004284A MX2011004284A MX2011004284A MX 2011004284 A MX2011004284 A MX 2011004284A MX 2011004284 A MX2011004284 A MX 2011004284A MX 2011004284 A MX2011004284 A MX 2011004284A MX 2011004284 A MX2011004284 A MX 2011004284A
- Authority
- MX
- Mexico
- Prior art keywords
- arterial hypertension
- pulmonary arterial
- treating pulmonary
- ht2a
- antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
La hipertensión arterial pulmonar en un mamífero se puede prevenir o tratar utilizando un antagonista de receptor 5-HT2A y 5-HT2B combinado. Los antagonistas pueden estar presentes en un compuesto individual o en dos compuestos separados.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10738208P | 2008-10-22 | 2008-10-22 | |
PCT/US2009/060458 WO2010047999A2 (en) | 2008-10-22 | 2009-10-13 | Method for treating pulmonary arterial hypertension |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011004284A true MX2011004284A (es) | 2011-06-21 |
Family
ID=42103846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011004284A MX2011004284A (es) | 2008-10-22 | 2009-10-13 | Metodo para tratar la hipertension arterial pulmonar. |
Country Status (10)
Country | Link |
---|---|
US (1) | US8324247B2 (es) |
EP (1) | EP2346511A2 (es) |
JP (1) | JP2012506434A (es) |
KR (1) | KR20110086803A (es) |
CN (1) | CN102186482A (es) |
AU (1) | AU2009307901A1 (es) |
CA (1) | CA2739489A1 (es) |
MX (1) | MX2011004284A (es) |
RU (1) | RU2011120347A (es) |
WO (1) | WO2010047999A2 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005294265A1 (en) * | 2004-10-06 | 2006-04-20 | University Of Rochester | Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway |
FI3821891T3 (fi) * | 2011-05-02 | 2023-08-24 | Univ Leland Stanford Junior | FK506:n käyttö pulmonaarisen valtimohypertension hoidossa |
US11478483B2 (en) * | 2017-09-08 | 2022-10-25 | Cipla Limited | Method of treating hypertension |
US20190125756A1 (en) * | 2017-11-01 | 2019-05-02 | Cipla Limited | Method of treating hypertension |
CN116148471B (zh) * | 2022-11-01 | 2024-05-07 | 中南大学 | 肺动脉高压的生物标志物及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780487A (en) * | 1995-08-07 | 1998-07-14 | Amer Moh Samir | S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide |
WO2005063220A1 (en) * | 2003-12-23 | 2005-07-14 | Board Of Regents, The University Of Texas System | Modulation of 5-ht2 receptors as a treatment for cardiovascular diseases |
WO2008061966A2 (en) * | 2006-11-22 | 2008-05-29 | Boehringer Ingelheim International Gmbh | New use of flibanserin |
-
2009
- 2009-10-13 KR KR1020117009007A patent/KR20110086803A/ko not_active Application Discontinuation
- 2009-10-13 JP JP2011533233A patent/JP2012506434A/ja active Pending
- 2009-10-13 WO PCT/US2009/060458 patent/WO2010047999A2/en active Application Filing
- 2009-10-13 CA CA2739489A patent/CA2739489A1/en not_active Abandoned
- 2009-10-13 AU AU2009307901A patent/AU2009307901A1/en not_active Abandoned
- 2009-10-13 MX MX2011004284A patent/MX2011004284A/es not_active Application Discontinuation
- 2009-10-13 EP EP09744259A patent/EP2346511A2/en not_active Withdrawn
- 2009-10-13 CN CN2009801414730A patent/CN102186482A/zh active Pending
- 2009-10-13 RU RU2011120347/15A patent/RU2011120347A/ru not_active Application Discontinuation
- 2009-10-13 US US12/577,795 patent/US8324247B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US8324247B2 (en) | 2012-12-04 |
JP2012506434A (ja) | 2012-03-15 |
CN102186482A (zh) | 2011-09-14 |
CA2739489A1 (en) | 2010-04-29 |
US20100099707A1 (en) | 2010-04-22 |
KR20110086803A (ko) | 2011-08-01 |
AU2009307901A1 (en) | 2010-04-29 |
EP2346511A2 (en) | 2011-07-27 |
WO2010047999A3 (en) | 2010-07-15 |
WO2010047999A2 (en) | 2010-04-29 |
RU2011120347A (ru) | 2012-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20141038T1 (en) | Benzoimidazoles as prolyl hydroxylase inhibitors | |
EA201071234A1 (ru) | Производные изохинолинона в качестве nk3 антагонистов | |
EP2244575A4 (en) | ANTAGONISTS OF THE ANGIOTENSIN II RECEPTOR | |
PT2037967T (pt) | Antagonistas do recetor de prostaglandina d2 para o tratamento da alopecia androgenética | |
EP2281196A4 (en) | METHODS, DEVICES, KITS AND COMPOSITIONS FOR DETECTING SWEEPING, PEAKING AND HOOKING JEWELS | |
HUS1800044I1 (hu) | Angiotenzin-II-receptor antagonisták macskák magas vérnyomásának kezelésére | |
IL195821A0 (en) | Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors | |
EP2480077A4 (en) | Novel pyrrolidines as glucagonone receptor agonists, compositions thereof, and methods of use | |
IL185726A0 (en) | Benzimidazole derivative and use as angiotensin ii antagonist | |
EP2365749A4 (en) | QUINOLONE ANTAGONISTS OF THE NEUROPEPTIDE S RECEPTOR | |
EP2254413A4 (en) | IMIDAZOBENZAZEPIN-CGRP receptor antagonists | |
IL201012A0 (en) | Quinoline derivatives as crth2 receptor ligands | |
GB0916577D0 (en) | Self-tightening drill chuck | |
TR201903101T4 (tr) | Miyokard enfarktüsün TGF-beta antagonistleri kullanılarak tedavisi. | |
IL187426A0 (en) | Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists | |
EP2378877A4 (en) | IMIDAZOLINONE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS | |
MX2011004284A (es) | Metodo para tratar la hipertension arterial pulmonar. | |
GB2463557B (en) | Locking chuck jaws | |
AP2009005047A0 (en) | Azetidine derivatives and their use as prostaglandin E2 antagonists | |
SI3456340T1 (sl) | Antagonisti receptorja za GLP-1 za uporabo pri zdravljenju prirojenega hiperinsulinizma | |
IL209266A0 (en) | Pyrrolidine derivatives as nk2 receptor antagonists | |
EP2365748A4 (en) | IMIDAZOISOINDOLA ANTAGONISTS OF NEUROPEPTIDE S RECEPTORS | |
EP2341919A4 (en) | CGRP RECEPTOR ANTAGONISTS | |
EP2340025A4 (en) | CGRP RECEPTOR ANTAGONISTS | |
ZA200609846B (en) | Mercaptoimidazoles as CCR2 receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |